1. Home
  2. YMAB vs RCKY Comparison

YMAB vs RCKY Comparison

Compare YMAB & RCKY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • YMAB
  • RCKY
  • Stock Information
  • Founded
  • YMAB 2015
  • RCKY 1932
  • Country
  • YMAB United States
  • RCKY United States
  • Employees
  • YMAB N/A
  • RCKY N/A
  • Industry
  • YMAB Biotechnology: Pharmaceutical Preparations
  • RCKY Shoe Manufacturing
  • Sector
  • YMAB Health Care
  • RCKY Consumer Discretionary
  • Exchange
  • YMAB Nasdaq
  • RCKY Nasdaq
  • Market Cap
  • YMAB 192.4M
  • RCKY 174.1M
  • IPO Year
  • YMAB 2018
  • RCKY 1993
  • Fundamental
  • Price
  • YMAB $8.51
  • RCKY $26.58
  • Analyst Decision
  • YMAB Buy
  • RCKY Hold
  • Analyst Count
  • YMAB 11
  • RCKY 1
  • Target Price
  • YMAB $15.02
  • RCKY $30.00
  • AVG Volume (30 Days)
  • YMAB 1.3M
  • RCKY 63.2K
  • Earning Date
  • YMAB 08-08-2025
  • RCKY 07-29-2025
  • Dividend Yield
  • YMAB N/A
  • RCKY 2.30%
  • EPS Growth
  • YMAB N/A
  • RCKY 24.23
  • EPS
  • YMAB N/A
  • RCKY 2.48
  • Revenue
  • YMAB $88,658,000.00
  • RCKY $462,328,000.00
  • Revenue This Year
  • YMAB N/A
  • RCKY $6.67
  • Revenue Next Year
  • YMAB $15.23
  • RCKY $4.25
  • P/E Ratio
  • YMAB N/A
  • RCKY $10.87
  • Revenue Growth
  • YMAB 4.92
  • RCKY N/A
  • 52 Week Low
  • YMAB $3.55
  • RCKY $11.93
  • 52 Week High
  • YMAB $16.11
  • RCKY $33.04
  • Technical
  • Relative Strength Index (RSI)
  • YMAB 81.64
  • RCKY 61.09
  • Support Level
  • YMAB $4.16
  • RCKY $24.68
  • Resistance Level
  • YMAB $8.54
  • RCKY $28.00
  • Average True Range (ATR)
  • YMAB 0.24
  • RCKY 1.37
  • MACD
  • YMAB 0.47
  • RCKY 0.23
  • Stochastic Oscillator
  • YMAB 99.32
  • RCKY 49.10

About YMAB Y-mAbs Therapeutics Inc.

Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.

About RCKY Rocky Brands Inc.

Rocky Brands Inc acts as a designer, manufacturer, and marketer of premium-quality footwear and apparel. The company's family of brands includes Rocky, Georgia Boot, Durango, Lehigh, Creative Recreation, and the licensed brand Michelin footwear. The company operates its business through three business segments: Wholesale, Retail and Contract Manufacturing. It generates the majority of the revenue from the Wholesale segment.

Share on Social Networks: